Medicare Enrolled

Dr. Jordan Buess, M.D.

Internal Medicine · Tyler, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
501 SAUNDERS AVE STE 200, Tyler, TX 75702
9035799800
In practice since 2016 (9 years)
NPI: 1811347735 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Buess from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Buess? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Buess

Dr. Jordan Buess is an internal medicine specialist in Tyler, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Buess performed 33,207 Medicare services across 1,333 unique beneficiaries.

Between the years covered by Open Payments, Dr. Buess received a total of $3,135 from 39 pharmaceutical and/or device companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Buess is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 1% volume in TX $3,135 industry payments

Medicare Practice Summary

Medicare Utilization ↗
33,207
Medicare services
Top 1% in TX for internal medicine
1,333
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,690 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 7,140 $0 $5
Oxaliplatin chemotherapy injection 6,500 $0 $33
Pembrolizumab injection (Keytruda) 6,000 $44 $139
Iron sucrose injection (Venofer) 4,200 $0 $2
Paclitaxel chemotherapy injection 3,152 $0 $8
Immune globulin infusion (Octagam) 1,290 $35 $235
Dexamethasone injection (steroid) 1,033 $0 $1
Denosumab injection (Prolia/Xgeva) 960 $19 $68
Injection, granisetron hydrochloride, 100 mcg 320 $0 $24
Injection, leucovorin calcium, per 50 mg 292 $4 $25
Injection of additional new drug or substance into vein 247 $12 $108
Injection, fluorouracil, 500 mg 184 $2 $13
Anti-nausea injection (Aloxi/palonosetron) 180 $1 $114
Administration of chemotherapy into vein, 1 hour or less 166 $98 $707
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 117 $3 $373
Blood draw (venipuncture) 116 $8 $20
Comprehensive metabolic blood panel 110 $10 $64
Complete blood count (CBC) with differential 106 $7 $36
Injection, zoledronic acid, 1 mg 100 $6 $431
Injection, carboplatin, 50 mg 88 $2 $300
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 78 $22 $157
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 71 $48 $313
Injection, diphenhydramine hcl, up to 50 mg 62 $1 $7
Injection, magnesium sulfate, per 500 mg 58 $1 $6
Drug injection, under skin or into muscle 48 $11 $96
Administration of chemotherapy into vein, each additional hour 47 $21 $161
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 46 $55 $211
Office visit, established patient, complex (40-54 min) 46 $137 $496
Administration of additional new drug or substance into vein, 1 hour or less 44 $49 $344
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 38 $366 $1,722
Iron level test 29 $6 $27
Iron binding capacity test 29 $8 $35
Ferritin level test (iron stores) 28 $13 $60
Lactate dehydrogenase (enzyme) level 28 $6 $31
New patient office visit, complex (60-74 min) 28 $168 $709
Unclassified drugs 26 $1 $8
Infusion, normal saline solution , 1000 cc 26 $2 $19
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 25 $16 $100
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l 20 $124 $500
Magnesium level test 19 $7 $29
Red blood count, automated test 19 $4 $23
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 18 $15 $94
Vitamin B-12 level test 15 $15 $76
Administration of additional new drug or substance into vein using push technique 15 $42 $289
New patient office visit (45-59 min) 15 $120 $565
Office visit, established patient (30-39 min) 15 $98 $368
Office visit, established patient (20-29 min) 13 $62 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.1% high complexity
71.8% medium
2.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,135
Total received (2020-2024)
Avg $627/year across 5 years
Top 23% in TX for internal medicine
39
Companies
103
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,175 (69.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$960 (30.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,899
2023
$589
2022
$148
2021
$235
2020
$264

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$364
ABBVIE INC.
$282
AstraZeneca Pharmaceuticals LP
$239
Astellas Pharma US Inc
$221
Seagen Inc.
$214
Tempus AI, Inc
$182
Incyte Corporation
$127
Pharmacosmos Therapeutics Inc.
$126
Amgen Inc.
$124
Pharmacyclics LLC, An AbbVie Company
$112
Daiichi Sankyo Inc.
$97
GENZYME CORPORATION
$93
SANOFI-AVENTIS U.S. LLC
$91
SOBI, INC
$73
Rigel Pharmaceuticals, Inc.
$70
Alexion Pharmaceuticals, Inc.
$60
GlaxoSmithKline, LLC.
$48
E.R. Squibb & Sons, L.L.C.
$45
Novartis Pharmaceuticals Corporation
$41
PFIZER INC.
$41
Janssen Biotech, Inc.
$39
Genmab U.S., Inc.
$37
Celgene Corporation
$36
ARRAY BIOPHARMA INC
$33
Blueprint Medicines Corporation
$33
Immunocore Limited
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$28
Aveo Pharmaceuticals, Inc.
$28
Regeneron Healthcare Solutions, Inc.
$27
Stemline Therapeutics Inc.
$26
G1 Therapeutics, Inc.
$24
Sobi, Inc
$21
BeiGene USA, Inc.
$21
Adaptive Biotechnologies Corporation
$17
Sumitomo Pharma America, Inc.
$17
Genentech USA, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$13
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 28.2% of total payments
Associated products mentioned in payments ›
AYVAKIT · BOSULIF · BRUKINSA · COSELA · CYRAMZA · DOPTELET · ELREXFIO · ENHERTU · EPKINLY · Enhertu · Epkinly · FOTIVDA · GAMIFANT · IMBRUVICA · IMFINZI · IMJUDO · JEMPERLI · KIMMTRAK · KISQALI · LIBTAYO · LORBRENA · Lunsumio · MONJUVI · MONOFERRIC · Nubeqa · OJJAARA · ORGOVYX · Orserdu · Padcev · REBLOZYL · RETEVMO · SARCLISA · Stivarga · TECVAYLI · TUKYSA · Tavalisse · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · XALKORI · XARELTO · XT CDX · Xospata · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $9 per 100 Medicare services performed
Looking for an internal medicine specialist in Tyler?
Compare internal medicine physicians in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
170
Per 100K population
71.4
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Buess is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Buess experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Buess performed 7,140 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Buess receive payments from pharmaceutical companies?
Yes. Dr. Buess received a total of $3,135 from 39 companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Buess's costs compare to other internal medicine physicians in Tyler?
Dr. Buess's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Buess) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →